Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Prelude Therapeutics Inc (PRLD)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 43,700,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Prelude Therapeutics is a clinical-stage oncology company built on a foundation of drug discovery to deliver precision cancer medicines to underserved patients. Co.'s primary candidates are designed to be oral, potent and selective inhibitors of protein arginine methyltransferase 5 (PRMT5). PRT811, Co.'s second clinical candidate, is a PRMT5 inhibitor that it has optimized for high brain exposure. PRT1419, Co.'s third clinical candidate, is designed to be a potent and selective inhibitor of the anti-apoptotic protein, MCL1. PRT2527, Co.'s fourth clinical candidate, is designed to be a potent and selective Cyclin-dependent kinase 9 inhibitor.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 1,760,286 1,799,474
Total Buy Value $0 $0 $10,116,973 $10,305,319
Total People Bought 0 0 5 5
Total Buy Transactions 0 0 7 10
Total Shares Sold 0 0 0 13,280
Total Sell Value $0 $0 $0 $81,274
Total People Sold 0 0 0 1
Total Sell Transactions 0 0 0 1
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 100
  Page 1 of 4  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Huang Jane President, CMO   •       –      –    2024-04-04 4 D $4.74 $15,865 D/D (3,347) 51,287     -
   Huang Jane President, CMO   •       –      –    2024-04-04 4 OE $0.00 $0 D/D 9,375 54,634     -
   Huang Jane President, CMO   •       –      –    2024-01-04 4 D $3.77 $14,492 D/D (3,844) 45,259     -
   Huang Jane President, CMO   •       –      –    2024-01-04 4 OE $0.00 $0 D/D 9,375 49,103     -
   Huang Jane President, CMO   •       –      –    2023-10-04 4 OE $0.00 $0 D/D 9,375 39,728     -
   Huang Jane President, CMO   •       –      –    2023-07-04 4 D $4.65 $15,075 D/D (3,242) 30,353     -
   Huang Jane President, CMO   •       –      –    2023-07-04 4 OE $0.00 $0 D/D 9,375 33,595     -
   Vaddi Krishna CEO   •       •      –    2023-05-25 4 B $5.31 $4,779 D/D 900 1,067,275 0.01     -
   Vaddi Krishna CEO   •       •      –    2023-05-24 4 B $5.01 $5,011 D/D 1,000 1,066,375 0.01     -
   Lim Bryant David Chief Legal Officer, Corp Sec.   •       –      –    2023-05-24 4 B $5.39 $12,936 D/D 2,400 2,400 0.01     -
   Vaddi Krishna CEO   •       •      –    2023-05-23 4 B $5.63 $66,749 D/D 11,856 1,065,375 0.01     -
   Chardonnet Laurent Chief Financial Officer   •       –      –    2023-05-23 4 B $5.50 $27,500 D/D 5,000 42,165 0.01     -
   Orbimed Capital Llc Director   –       •       •   2023-05-22 4 B $5.75 $4,999,999 I/I 869,565 10,119,756 2.25     -
   Bonita David P Director   –       •       •   2023-05-22 4 B $5.75 $4,999,999 I/I 869,565 10,119,756 2.25     -
   Huang Jane President, CMO   •       –      –    2023-04-06 4 S $6.12 $81,274 D/D (13,280) 24,220     -
   Huang Jane President, CMO   •       –      –    2023-04-04 4 OE $0.00 $0 D/D 37,500 37,500     -
   Vaddi Krishna CEO   •       •      –    2022-12-20 4 B $5.13 $98,446 I/I 19,188 120,665 0.01     -
   Chardonnet Laurent Chief Financial Officer   •       –      –    2022-12-08 4 B $4.76 $47,600 D/D 10,000 35,873 0.01     -
   Chardonnet Laurent Chief Financial Officer   •       –      –    2022-06-01 4 B $4.23 $42,300 D/D 10,000 24,500 0.01     -
   Combs Andrew EVP, Head of Chemistry   •       –      –    2022-03-31 4 OE $1.89 $68,157 D/D 36,062 304,442     -
   Chardonnet Laurent Chief Financial Officer   •       –      –    2022-03-21 4 A $7.51 $48,815 D/D 6,500 14,500     -
   Morosini Deborah EVP, Chief of Clinical Affairs   •       –      –    2021-12-15 4 AS $13.00 $373,763 D/D (28,751) 444     -
   Morosini Deborah EVP, Chief of Clinical Affairs   •       –      –    2021-12-15 4 OE $1.89 $336,395 D/D 28,751 29,195     -
   Combs Andrew EVP, Head of Chemistry   •       –      –    2021-12-14 4 B $11.60 $46,400 D/D 4,000 268,380 2.74     -
   Combs Andrew EVP, Head of Chemistry   •       –      –    2021-12-13 4 B $12.12 $48,480 D/D 4,000 264,380 2.74     -
  100 Records found
  1  2  3  4   
  Page 1 of 4
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us